Connect with us

Hi, what are you looking for?

Wednesday, May 18, 2022
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.

Business

Aleafia extends obligations on $37.4M convertible debt

The firm says it has a cumulative deficit of $480.8M

Aleafia extends obligations on $37.4M convertible debt
Aleafia’s 86-acre Port Perry cannabis farm is located about one-hour outside of Toronto, Ontario. Press photo

Stalwart Canadian producer Aleafia Health Inc. (TSX: AH) (TSX: AH.DB) (OTCQX: ALEAF) is continuing to push back its obligations on a significant debt that comes due in a few months.

On Tuesday, the firm said the forbearance agreement with holders of its convertible debt has been extended until April 11. Around 62 per cent of the $37.4 million outstanding is currently due.

The agreement will automatically renew for two-week periods going forwards unless notice is given.

“The parties continue to work expeditiously and in good faith to negotiate a potential transaction to amend the terms associated with the convertible debt,” Aleafia says in a statement. “While there can be no assurances regarding any outcome, the Company believes progress is being made towards a solution that is beneficial to its stakeholders.”

Previously, the firm failed to pay a scheduled interest payment of $1.6 million on the debentures due Dec. 31.

Read more: Annual sales fall 6% to $43.1M for Aleafia

In June 2019, Aleafia issued over 40,000 convertible debentures for gross proceeds of $40 million. Each unit consists of one $1,000 principal amount of unsecured convertible debenture of the firm and 680 common share purchase warrants.

That debt has an annual interest rate of 8.5 per cent, payable semi-annually, and matures June 27.

According to the company’s fourth quarter and fiscal 2021 financial statements, the remaining principal balance to be paid upon maturity is $37.4 million.

Restating the “growing concern” status of its finances, Aleafia says it’s experienced recurring losses, has a cumulative deficit of $480.8 million, and a working capital deficiency of $21.4 million.

As of Dec. 31, the firm had $11.3 million in cash.

Company stock traded at $0.12 Tuesday on the Toronto Stock Exchange.

 

Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Follow Nick Laba on Twitter

nick@mugglehead.com

Click to comment

Leave a Reply

Your email address will not be published.

You May Also Like

Health and Safety

Science doesn't know yet, but one psychedelic researcher is chasing clues to see if it can

Canada

As more medium-to-small producers came into play this year, great weed started hitting legal shelves at fairer prices

Culture

Punishments for possession include caning and the death penalty. Despite a global trend of reform, The Fine City remains staunch in its anti-drug stance

Analysis

While legal weed businesses decry enforcement of their accounts, the platform says it's keeping its all-ages community safe